Segala D, Barbieri M, Di Nuzzo M, Benazzi M, Bonazza A, Romanini L, Quarta B, Scolz K, Marra A, Campioni D, Cultrera R. Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network. Grhta [Internet]. 2024 Jul. 29 [cited 2024 Sep. 12];11(Suppl. 2):5-12. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3094